Abstract
Despite being the highest group of users of many medications, older individuals remain underrepresented in clinical trials. This leaves a gap in evidence to guide management of many conditions, such as ischemic heart disease (IHD), in this population. This study aimed to describe factors associated with IHD medication use among nursing home residents in 7 European countries and Israel to depict challenges facing disease management in this population.
Lingua originale | English |
---|---|
pagine (da-a) | 410-415 |
Numero di pagine | 6 |
Rivista | Journal of the American Medical Directors Association |
Volume | 15 |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- Ischemic heart disease
- interRAI
- nursing home populations
- pharmacotherapy